Kite Pharma (KITE) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for Kite Pharma (KITE) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$7.572B||$0.022B|
|Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of cancer immunotherapy products. The Company is developing a pipeline of eACT-based product candidates for the treatment of solid and hematological malignancies. Kite Pharma, Inc. is headquartered in Santa Monica, California.|